QY Research > レポート一覧 > メディカルケア > トランスクリプトーム解析の世界市場レポート2025-2031

トランスクリプトーム解析の世界市場レポート2025-2031

英文タイトル: Global Transcriptome Sequencing Market Insights, Forecast to 2031

トランスクリプトーム解析の世界市場レポート2025-2031
  • レポートID:398091
  • 発表時期:2025-07-08
  • 訪問回数:379
  • ページ数:131
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:135
  • レポートカテゴリ: メディカルケア

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=147.60円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=147.60円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書は、トランスクリプトーム解析の世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にトランスクリプトーム解析市場を分類しています。

本レポートでは世界のトランスクリプトーム解析市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は:Illumina、Thermo Fisher Scientific、Eurofins Scientific、Roche、Bio-Rad、Agilent Technologies、LabCorp、QIAGEN、Pacific Biosciences、Azenta、BGI Genomics、Novogene、Macrogen、Shanghai ZJ Bio-Tech、Tsingke Biotechnology

レポートはトランスクリプトーム解析の主要生産者を調査し、主要地域や国の消費状況も提供します。トランスクリプトーム解析の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。

タイプ別市場セグメント:
Coding RNA
Noncoding RNA

用途別の市場セグメント:
Biomedical Field
Non-medical Field

レポートの詳細内容
本レポートは、世界のトランスクリプトーム解析市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてトランスクリプトーム解析市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。

一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別(地域レベル、国レベル)のトランスクリプトーム解析生産量、成長率、市場シェアを調査している。

二. 消費面では、トランスクリプトーム解析の売上高を地域別(地域レベル・国レベル)、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーのトランスクリプトーム解析売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界のトランスクリプトーム解析市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本トランスクリプトーム解析のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要

1章:トランスクリプトーム解析のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー(タイプ別およびアプリケーション別など)を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。(20202031
2章: トランスクリプトーム解析の世界と主要生産者(地域/国)の生産/アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。(20202031
3章:世界、地域、国レベルにおけるトランスクリプトーム解析の売上(消費)、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。(20202031
4トランスクリプトーム解析メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。(20202025
5章:トランスクリプトーム解析の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20202031
6章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。(20202031
7章:北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。(20202031
8章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高と収益。(20202031
9章:中国:タイプ別、アプリケーション別、セグメント別の売上高、収益。(20202031
10章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。(20202031
11章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。(20202031
12章:トランスクリプトーム解析の主要メーカーの概要を提供し、製品の説明と仕様、トランスクリプトーム解析の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。(20202025
13章:産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
14章:トランスクリプトーム解析の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
15章:レポートの要点と結論。

biaoTi

概要

The global Transcriptome Sequencing market is projected to grow from US$ 2742 million in 2025 to US$ 6073 million by 2031, at a Compound Annual Growth Rate (CAGR) of 14.2% during the forecast period.
Transcriptome sequencing employs high-throughput sequencing technologies to get access to almost all transcripts of specific tissues or cells in a certain state by comprehensive and rapid cDNA sequencing, becoming the basis as well as the starting point for the research of gene expression. The main objectives of transcriptome research include the classification of all transcriptional products, the determination of the transcription structure of genes (such as starting sites, 5′ and 3′ terminals, splicing patterns, and post-transcriptional modifications), and the changes in the expression levels of individual transcripts during development. This technology has been widely used in biological research, medical and clinical research, and drug development.
The key service providers of Transcriptome Sequencing in the world are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences and Eurofins Scientific, among which the top five providers account for more than 70% of the market share, and Illumina is the largest service provider. The cost of RNA-Seq has decreased significantly over the past decade, making it more accessible to researchers and clinicians. This cost reduction is driven by advancements in sequencing technologies and economies of scale. Transcriptome sequencing is playing a critical role in identifying patient-specific biomarkers and therapeutic targets. The growing focus on precision medicine is driving adoption in oncology, rare diseases, and pharmacogenomics. Increased funding for genomics and transcriptomics research from governments, non-profits, and private investors is supporting market growth. Initiatives like the Cancer Genome Atlas (TCGA) and Human Cell Atlas (HCA) are driving large-scale transcriptome studies.
In terms of production side, this report researches the Transcriptome Sequencing production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.

In terms of consumption side, this report focuses on the sales of Transcriptome Sequencing by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Transcriptome Sequencing, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Transcriptome Sequencing, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Transcriptome Sequencing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Transcriptome Sequencing sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Transcriptome Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. 
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Transcriptome Sequencing sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Illumina, Thermo Fisher Scientific, Eurofins Scientific, Roche, Bio-Rad, Agilent Technologies, LabCorp, QIAGEN, Pacific Biosciences, Azenta, etc.

Market Segmentation
By Company
    Illumina
    Thermo Fisher Scientific
    Eurofins Scientific
    Roche
    Bio-Rad
    Agilent Technologies
    LabCorp
    QIAGEN
    Pacific Biosciences
    Azenta
    BGI Genomics
    Novogene
    Macrogen
    Shanghai ZJ Bio-Tech
    Tsingke Biotechnology

Segment by Type
    Coding RNA
    Noncoding RNA

Segment by Application
    Biomedical Field
    Non-medical Field

Production by Region
    North America
    Europe
    China
    Japan

Sales by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Transcriptome Sequencing production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Transcriptome Sequencing in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Transcriptome Sequencing manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcriptome Sequencing sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
biaoTi

総目録

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcriptome Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Coding RNA
1.2.3 Noncoding RNA
1.3 Market by Application
1.3.1 Global Transcriptome Sequencing Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Biomedical Field
1.3.3 Non-medical Field
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Transcriptome Sequencing Market Perspective (2020-2031)
2.2 Global Transcriptome Sequencing Growth Trends by Region
2.2.1 Global Transcriptome Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transcriptome Sequencing Market Size by Region (2020-2031)
2.3 Transcriptome Sequencing Market Dynamics
2.3.1 Transcriptome Sequencing Industry Trends
2.3.2 Transcriptome Sequencing Market Drivers
2.3.3 Transcriptome Sequencing Market Challenges
2.3.4 Transcriptome Sequencing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue Transcriptome Sequencing by Players
3.1.1 Global Transcriptome Sequencing Revenue by Players (2020-2025)
3.1.2 Global Transcriptome Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Transcriptome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Transcriptome Sequencing, Ranking by Revenue, 2023 VS 2024 VS 2025
3.4 Global Market Concentration Ratio
3.4.1 Global Transcriptome Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcriptome Sequencing Revenue in 2024
3.5 Global Key Players of Transcriptome Sequencing Head office and Area Served
3.6 Global Key Players of Transcriptome Sequencing, Product and Application
3.7 Global Key Players of Transcriptome Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Transcriptome Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Transcriptome Sequencing Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application
5.1 Global Transcriptome Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Transcriptome Sequencing Forecasted Market Size by Application (2026-2031)

6 North America
6.1 North America Transcriptome Sequencing Market Size (2020-2031)
6.2 North America Market Size by Type
6.2.1 North America Transcriptome Sequencing Market Size by Type (2020-2031)
6.2.2 North America Transcriptome Sequencing Market Share by Type (2020-2031)
6.3 North America Market Size by Application
6.3.1 North America Transcriptome Sequencing Market Size by Application (2020-2031)
6.3.2 North America Transcriptome Sequencing Market Share by Application (2020-2031)
6.4 North America Market Size by Country
6.4.1 North America Transcriptome Sequencing Market Size by Country: 2020 VS 2024 VS 2031
6.4.2 North America Transcriptome Sequencing Market Size by Country (2020-2031)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Transcriptome Sequencing Market Size (2020-2031)
7.2 Europe Market Size by Type
7.2.1 Europe Transcriptome Sequencing Market Size by Type (2020-2031)
7.2.2 Europe Transcriptome Sequencing Market Share by Type (2020-2031)
7.3 Europe Market Size by Application
7.3.1 Europe Transcriptome Sequencing Market Size by Application (2020-2031)
7.3.2 Europe Transcriptome Sequencing Market Share by Application (2020-2031)
7.4 Europe Market Size by Country
7.4.1 Europe Transcriptome Sequencing Market Size by Country: 2020 VS 2024 VS 2031
7.4.2 Europe Transcriptome Sequencing Market Size by Country (2020-2025)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries

8 China
8.1 China Transcriptome Sequencing Market Size (2020-2031)
8.2 China Market Size by Type
8.2.1 China Transcriptome Sequencing Market Size by Type (2020-2031)
8.2.2 China Transcriptome Sequencing Market Share by Type (2020-2031)
8.3 China Market Size by Application
8.3.1 China Transcriptome Sequencing Market Size by Application (2020-2031)
8.3.2 China Transcriptome Sequencing Market Share by Application (2020-2031)

9 Asia (excluding China)
9.1 Asia Transcriptome Sequencing Market Size (2020-2031)
9.2 Asia Market Size by Type
9.2.1 Asia Transcriptome Sequencing Market Size by Type (2020-2031)
9.2.2 Asia Transcriptome Sequencing Market Share by Type (2020-2031)
9.3 Asia Market Size by Application
9.3.1 Asia Transcriptome Sequencing Market Size by Application (2020-2031)
9.3.2 Asia Transcriptome Sequencing Market Share by Application (2020-2031)
9.4 Asia Market Size by Region
9.4.1 Asia Transcriptome Sequencing Market Size by Region: 2020 VS 2024 VS 2031
9.4.2 Asia Transcriptome Sequencing Market Size by Region (2020-2031)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
9.4.8 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size (2020-2031)
10.2 Middle East, Africa, and Latin America Market Size by Type
10.2.1 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Type (2020-2031)
10.2.2 Middle East, Africa, and Latin America Transcriptome Sequencing Market Share by Type (2020-2031)
10.3 Middle East, Africa, and Latin America Market Size by Application
10.3.1 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Application (2020-2031)
10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
10.4 Middle East, Africa, and Latin America Market Size by Country
10.4.1 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Country: 2020 VS 2024 VS 2031
10.4.2 Middle East, Africa, and Latin America Transcriptome Sequencing Market Size by Country (2020-2031)
10.4.3 Brazil
10.4.4 Mexico
10.4.5 Turkey
10.4.6 Saudi Arabia
10.4.7 Israel
10.4.8 GCC Countries

11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Transcriptome Sequencing Introduction
11.1.4 Illumina Revenue in Transcriptome Sequencing Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Transcriptome Sequencing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Transcriptome Sequencing Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Transcriptome Sequencing Introduction
11.3.4 Eurofins Scientific Revenue in Transcriptome Sequencing Business (2020-2025)
11.3.5 Eurofins Scientific Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Transcriptome Sequencing Introduction
11.4.4 Roche Revenue in Transcriptome Sequencing Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Transcriptome Sequencing Introduction
11.5.4 Bio-Rad Revenue in Transcriptome Sequencing Business (2020-2025)
11.5.5 Bio-Rad Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Details
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Transcriptome Sequencing Introduction
11.6.4 Agilent Technologies Revenue in Transcriptome Sequencing Business (2020-2025)
11.6.5 Agilent Technologies Recent Development
11.7 LabCorp
11.7.1 LabCorp Company Details
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Transcriptome Sequencing Introduction
11.7.4 LabCorp Revenue in Transcriptome Sequencing Business (2020-2025)
11.7.5 LabCorp Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Details
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Transcriptome Sequencing Introduction
11.8.4 QIAGEN Revenue in Transcriptome Sequencing Business (2020-2025)
11.8.5 QIAGEN Recent Development
11.9 Pacific Biosciences
11.9.1 Pacific Biosciences Company Details
11.9.2 Pacific Biosciences Business Overview
11.9.3 Pacific Biosciences Transcriptome Sequencing Introduction
11.9.4 Pacific Biosciences Revenue in Transcriptome Sequencing Business (2020-2025)
11.9.5 Pacific Biosciences Recent Development
11.10 Azenta
11.10.1 Azenta Company Details
11.10.2 Azenta Business Overview
11.10.3 Azenta Transcriptome Sequencing Introduction
11.10.4 Azenta Revenue in Transcriptome Sequencing Business (2020-2025)
11.10.5 Azenta Recent Development
11.11 BGI Genomics
11.11.1 BGI Genomics Company Details
11.11.2 BGI Genomics Business Overview
11.11.3 BGI Genomics Transcriptome Sequencing Introduction
11.11.4 BGI Genomics Revenue in Transcriptome Sequencing Business (2020-2025)
11.11.5 BGI Genomics Recent Development
11.12 Novogene
11.12.1 Novogene Company Details
11.12.2 Novogene Business Overview
11.12.3 Novogene Transcriptome Sequencing Introduction
11.12.4 Novogene Revenue in Transcriptome Sequencing Business (2020-2025)
11.12.5 Novogene Recent Development
11.13 Macrogen
11.13.1 Macrogen Company Details
11.13.2 Macrogen Business Overview
11.13.3 Macrogen Transcriptome Sequencing Introduction
11.13.4 Macrogen Revenue in Transcriptome Sequencing Business (2020-2025)
11.13.5 Macrogen Recent Development
11.14 Shanghai ZJ Bio-Tech
11.14.1 Shanghai ZJ Bio-Tech Company Details
11.14.2 Shanghai ZJ Bio-Tech Business Overview
11.14.3 Shanghai ZJ Bio-Tech Transcriptome Sequencing Introduction
11.14.4 Shanghai ZJ Bio-Tech Revenue in Transcriptome Sequencing Business (2020-2025)
11.14.5 Shanghai ZJ Bio-Tech Recent Development
11.15 Tsingke Biotechnology
11.15.1 Tsingke Biotechnology Company Details
11.15.2 Tsingke Biotechnology Business Overview
11.15.3 Tsingke Biotechnology Transcriptome Sequencing Introduction
11.15.4 Tsingke Biotechnology Revenue in Transcriptome Sequencing Business (2020-2025)
11.15.5 Tsingke Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

biaoTi

表と図のリスト

List of Tables
 Table 1. Global Transcriptome Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Coding RNA
 Table 3. Key Players of Noncoding RNA
 Table 4. Global Transcriptome Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Transcriptome Sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Market Size by Region (2020-2031) & (US$ Million)
 Table 7. Global Transcriptome Sequencing Market Share by Region (2020-2031)
 Table 8. Market Trends
 Table 9. Market Drivers
 Table 10. Market Challenges
 Table 11. Market Restraints
 Table 12. Global Transcriptome Sequencing Revenue by Players (2020-2025) & (US$ Million)
 Table 13. Global Transcriptome Sequencing Market Share by Players (2020-2025)
 Table 14. Global Top Transcriptome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptome Sequencing as of 2024)
 Table 15. Global Transcriptome Sequencing Industry Ranking 2023 VS 2024
 Table 16. Global 5 Largest Players Market Share by Transcriptome Sequencing Revenue (CR5 and HHI) & (2020-2025)
 Table 17. Global Key Players of Transcriptome Sequencing, Headquarters and Area Served
 Table 18. Global Key Players of Transcriptome Sequencing, Product and Application
 Table 19. Global Key Players of Transcriptome Sequencing, Date of Enter into This Industry
 Table 20. Mergers & Acquisitions, Expansion Plans
 Table 21. Global Market Size by Type (2020-2025) & (US$ Million)
 Table 22. Global Transcriptome Sequencing Revenue Market Share by Type (2020-2025)
 Table 23. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 24. Global Transcriptome Sequencing Revenue Market Share by Type (2026-2031)
 Table 25. Global Market Size by Application (2020-2025) & (US$ Million)
 Table 26. Global Transcriptome Sequencing Revenue Market Share by Application (2020-2025)
 Table 27. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 28. Global Transcriptome Sequencing Revenue Market Share by Application (2026-2031)
 Table 29. North America Market Size by Type (2020-2031) & (US$ Million)
 Table 30. North America Market Size by Application (2020-2031) & (US$ Million)
 Table 31. North America Transcriptome Sequencing Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Market Size by Country (2020-2031) & (US$ Million)
 Table 33. Europe Market Size by Type (2020-2031) & (US$ Million)
 Table 34. Europe Market Size by Application (2020-2031) & (US$ Million)
 Table 35. Europe Transcriptome Sequencing Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Market Size by Country (2020-2025) & (US$ Million)
 Table 37. China Market Size by Type (2020-2031) & (US$ Million)
 Table 38. China Market Size by Application (2020-2031) & (US$ Million)
 Table 39. Asia Market Size by Type (2020-2031) & (US$ Million)
 Table 40. Asia Market Size by Application (2020-2025) & (US$ Million)
 Table 41. Asia Transcriptome Sequencing Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia Market Size by Region (2020-2031) & (US$ Million)
 Table 43. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)
 Table 44. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)
 Table 45. Middle East, Africa, and Latin America Transcriptome Sequencing Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)
 Table 47. Illumina Company Details
 Table 48. Illumina Business Overview
 Table 49. Illumina Transcriptome Sequencing Product
 Table 50. Illumina Revenue (2020-2025) & (US$ Million)
 Table 51. Illumina Recent Development
 Table 52. Thermo Fisher Scientific Company Details
 Table 53. Thermo Fisher Scientific Business Overview
 Table 54. Thermo Fisher Scientific Transcriptome Sequencing Product
 Table 55. Thermo Fisher Scientific Revenue (2020-2025) & (US$ Million)
 Table 56. Thermo Fisher Scientific Recent Development
 Table 57. Eurofins Scientific Company Details
 Table 58. Eurofins Scientific Business Overview
 Table 59. Eurofins Scientific Transcriptome Sequencing Product
 Table 60. Eurofins Scientific Revenue (2020-2025) & (US$ Million)
 Table 61. Eurofins Scientific Recent Development
 Table 62. Roche Company Details
 Table 63. Roche Business Overview
 Table 64. Roche Transcriptome Sequencing Product
 Table 65. Roche Revenue (2020-2025) & (US$ Million)
 Table 66. Roche Recent Development
 Table 67. Bio-Rad Company Details
 Table 68. Bio-Rad Business Overview
 Table 69. Bio-Rad Transcriptome Sequencing Product
 Table 70. Bio-Rad Revenue (2020-2025) & (US$ Million)
 Table 71. Bio-Rad Recent Development
 Table 72. Agilent Technologies Company Details
 Table 73. Agilent Technologies Business Overview
 Table 74. Agilent Technologies Transcriptome Sequencing Product
 Table 75. Agilent Technologies Revenue (2020-2025) & (US$ Million)
 Table 76. Agilent Technologies Recent Development
 Table 77. LabCorp Company Details
 Table 78. LabCorp Business Overview
 Table 79. LabCorp Transcriptome Sequencing Product
 Table 80. LabCorp Revenue (2020-2025) & (US$ Million)
 Table 81. LabCorp Recent Development
 Table 82. QIAGEN Company Details
 Table 83. QIAGEN Business Overview
 Table 84. QIAGEN Transcriptome Sequencing Product
 Table 85. QIAGEN Revenue (2020-2025) & (US$ Million)
 Table 86. QIAGEN Recent Development
 Table 87. Pacific Biosciences Company Details
 Table 88. Pacific Biosciences Business Overview
 Table 89. Pacific Biosciences Transcriptome Sequencing Product
 Table 90. Pacific Biosciences Revenue (2020-2025) & (US$ Million)
 Table 91. Pacific Biosciences Recent Development
 Table 92. Azenta Company Details
 Table 93. Azenta Business Overview
 Table 94. Azenta Transcriptome Sequencing Product
 Table 95. Azenta Revenue (2020-2025) & (US$ Million)
 Table 96. Azenta Recent Development
 Table 97. BGI Genomics Company Details
 Table 98. BGI Genomics Business Overview
 Table 99. BGI Genomics Transcriptome Sequencing Product
 Table 100. BGI Genomics Revenue (2020-2025) & (US$ Million)
 Table 101. BGI Genomics Recent Development
 Table 102. Novogene Company Details
 Table 103. Novogene Business Overview
 Table 104. Novogene Transcriptome Sequencing Product
 Table 105. Novogene Revenue (2020-2025) & (US$ Million)
 Table 106. Novogene Recent Development
 Table 107. Macrogen Company Details
 Table 108. Macrogen Business Overview
 Table 109. Macrogen Transcriptome Sequencing Product
 Table 110. Macrogen Revenue (2020-2025) & (US$ Million)
 Table 111. Macrogen Recent Development
 Table 112. Shanghai ZJ Bio-Tech Company Details
 Table 113. Shanghai ZJ Bio-Tech Business Overview
 Table 114. Shanghai ZJ Bio-Tech Transcriptome Sequencing Product
 Table 115. Shanghai ZJ Bio-Tech Revenue (2020-2025) & (US$ Million)
 Table 116. Shanghai ZJ Bio-Tech Recent Development
 Table 117. Tsingke Biotechnology Company Details
 Table 118. Tsingke Biotechnology Business Overview
 Table 119. Tsingke Biotechnology Transcriptome Sequencing Product
 Table 120. Tsingke Biotechnology Revenue (2020-2025) & (US$ Million)
 Table 121. Tsingke Biotechnology Recent Development
 Table 122. Research Programs/Design for This Report
 Table 123. Key Data Information from Secondary Sources
 Table 124. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Transcriptome Sequencing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 2. Global Transcriptome Sequencing Market Share by Type: 2024 VS 2031
 Figure 3. Coding RNA Features
 Figure 4. Noncoding RNA Features
 Figure 5. Global Transcriptome Sequencing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Global Transcriptome Sequencing Market Share by Application: 2024 VS 2031
 Figure 7. Biomedical Field Case Studies
 Figure 8. Non-medical Field Case Studies
 Figure 9. Transcriptome Sequencing Report Years Considered
 Figure 10. Global Transcriptome Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 11. Global Transcriptome Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Transcriptome Sequencing Market Share by Region: 2024 VS 2031
 Figure 13. Global Transcriptome Sequencing Market Share by Players in 2024
 Figure 14. Global Top Transcriptome Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptome Sequencing as of 2024)
 Figure 15. The Top 10 and 5 Players Market Share by Transcriptome Sequencing Revenue in 2024
 Figure 16. North America Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 17. North America Transcriptome Sequencing Market Share by Type (2020-2031)
 Figure 18. North America Transcriptome Sequencing Market Share by Application (2020-2031)
 Figure 19. North America Transcriptome Sequencing Market Share by Country (2020-2031)
 Figure 20. United States Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Transcriptome Sequencing Market Share by Type (2020-2031)
 Figure 24. Europe Transcriptome Sequencing Market Share by Application (2020-2031)
 Figure 25. Europe Transcriptome Sequencing Market Share by Country (2020-2031)
 Figure 26. Germany Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. China Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. China Transcriptome Sequencing Market Share by Type (2020-2031)
 Figure 34. China Transcriptome Sequencing Market Share by Application (2020-2031)
 Figure 35. Asia Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia Transcriptome Sequencing Market Share by Type (2020-2031)
 Figure 37. Asia Transcriptome Sequencing Market Share by Application (2020-2031)
 Figure 38. Asia Transcriptome Sequencing Market Share by Region (2020-2031)
 Figure 39. Japan Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East, Africa, and Latin America Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East, Africa, and Latin America Transcriptome Sequencing Market Share by Type (2020-2031)
 Figure 47. Middle East, Africa, and Latin America Transcriptome Sequencing Market Share by Application (2020-2031)
 Figure 48. Middle East, Africa, and Latin America Transcriptome Sequencing Market Share by Country (2020-2031)
 Figure 49. Brazil Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Mexico Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Turkey Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Israel Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. GCC Countries Transcriptome Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. Illumina Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 57. Eurofins Scientific Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 58. Roche Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 59. Bio-Rad Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 60. Agilent Technologies Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 61. LabCorp Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 62. QIAGEN Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 63. Pacific Biosciences Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 64. Azenta Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 65. BGI Genomics Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 66. Novogene Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 67. Macrogen Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 68. Shanghai ZJ Bio-Tech Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 69. Tsingke Biotechnology Revenue Growth Rate in Transcriptome Sequencing Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)